tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Anteris Technologies Postpones Special Stockholders Meeting

Story Highlights
  • Anteris postponed its Special Meeting to September 18, 2025, for broader stockholder participation.
  • The board recommends voting for proposals, highlighting Anteris’ commitment to stakeholder engagement.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Anteris Technologies Postpones Special Stockholders Meeting

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Anteris Technologies Global Corp. ( (AVR) ) has provided an update.

On September 11, 2025, Anteris Technologies Global Corp. announced the postponement of its Special Meeting of Stockholders to September 18, 2025, to allow additional time for stockholders to vote and ensure broader participation. The company’s board unanimously recommends voting in favor of the proposals in the Proxy Statement, and the record date remains unchanged. This decision reflects Anteris’ commitment to engaging its stakeholders effectively and may influence its strategic direction depending on the outcomes of the stockholder votes.

The most recent analyst rating on (AVR) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Anteris Technologies Global Corp. stock, see the AVR Stock Forecast page.

Spark’s Take on AVR Stock

According to Spark, TipRanks’ AI Analyst, AVR is a Neutral.

Anteris Technologies Global Corp. has a low overall stock score due to significant financial challenges, including declining revenues and persistent losses. The technical analysis indicates a bearish trend, and the valuation is unattractive with a negative P/E ratio. However, the recent ASX waiver for securities issuance is a positive corporate event, providing potential strategic opportunities.

To see Spark’s full report on AVR stock, click here.

More about Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a global structural heart company focused on designing, developing, and commercializing innovative medical devices to restore healthy heart function. The company, founded in Australia and with a significant presence in Minneapolis, USA, offers solutions for structural heart disease, including its lead product, the DurAVR® Transcatheter Heart Valve, designed to treat aortic stenosis.

Average Trading Volume: 190,870

Technical Sentiment Signal: Strong Buy

Current Market Cap: $173.8M

For an in-depth examination of AVR stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1